Performance status of male and female advanced cancer patients is independently predicted by mid-upper arm circumference measurement

Nutrition and Cancer

Volumn 42, Issue 2, 2002, Pages 191-193

  McMillan, Donald C ^a   Forrest, Lynn M ^a   O’morman, Patricia ^a   Angerson, Wilson J ^a   McArdle, Colin S ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARM; ARTICLE; CANCER PATIENT; CANCER STAGING; DIGESTIVE SYSTEM CANCER; FEMALE; GENDER; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PROGNOSIS; SKINFOLD THICKNESS; TUMOR CLASSIFICATION; WEIGHT REDUCTION;

AGED; ANTHROPOMETRY; ARM; C-REACTIVE PROTEIN; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; WEIGHT LOSS;

EID: 0036032948     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914NC422_7     Document Type: Article

References (12)

1. Bruera E: ABC of palliative care. Anorexia, cachexia, and nutrition. Br Med J 315, 1219-1222, 1997.
2. O'Gorman P, McMillan DC, and McArdle CS: Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer 32, 76-80, 1998.
3. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, et al.: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastem Cooperative Oncology Group. Am J Med 69, 491-497, 1980.
4. O'Gorman P, McMillan DC, and McArdle CS: Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 37, 36-40, 2000.
5. Kotler DP: Cachexia. Ann Intern Med 133, 622-634, 2000.
6. Scott HR, McMillan DC, Watson WS, Milroy R, and McArdle S: Longitudinal study of resting energy expenditure, body cell mass and the inflammatory response in male patients with non-small cell lung cancer. Lung Cancer 32, 307-312, 2001.
7. McMillan DC, Scott HR, Watson WS, Preston T, Milroy R, et al.: Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31, 101-105, 1998.
8. Barber MD, Ross JA, and Fearon KC: Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer 35, 106-110, 1999.
9. Barber MD, Fearon KC, McMillan DC, Slater C, Ross JA, et al.: Liver export protein synthetic rates are increased by oral meal feeding in weight-losing cancer patients. Am J Physiol 279, E707-E714, 2000.
10. McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, et al.: Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39, 210-213, 2001.
11. Gabay C and Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340, 448-454, 1999.
12. McMillan DC, Wigmore SJ, Fearon KC, O'Gorman P, Wright CE, et al.: A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Br J Cancer 79, 495-500, 1999.